Tsumura & co (4540) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Tsumura & co (Tsumura) is a traditional pharmaceutical products company, which undertakes the manufacturing and sale of Kampo extract intermediates and granular Kampo formulations. Its product portfolio includes a range of prescription Kampo products, other pharmaceuticals, over-the-counter (OTC) formulations, Chinese crude drug pieces for decoction and other products. The company provides Kampo products for treating abdominal pain and flatulence, neurosis, insomnia, anorexia, gastritis, maldigestion, cough, bronchitis, bronchial asthma, oversensitivity to cold, menstrual irregularity, climacteric disturbance, leg pain, low back pain, numbness, dysuria, swelling (edema), acute gastroenteritis, common cold, coryza, shoulder stiffness, stomatitis, fermentative diarrhea, neurotic gastritis and other diseases. The company along with its subsidiaries operates in the US, China and Japan. Tsumura is headquartered in Minato-ku, Tokyo, Japan.

Tsumura & co (4540) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tsumura & co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tsumura & co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tsumura & co, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Tsumura Forms Joint Venture with Ping An Insurance 10
Tsumura Plans to Form Joint Venture with Tianjin-based Drug Firm 11
Equity Offering 12
Tsumura Raises USD243 Million in Public Offering of Shares 12
Debt Offering 13
Tsumura to Raise USD134.3 Million in Public Offering of 0.23% Bonds Due 2024 13
Tsumura to Raise USD134.3 Million in Public Offering of 0.345% Bonds Due 2027 14
Tsumura & co - Key Competitors 15
Tsumura & co - Key Employees 16
Tsumura & co - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables


Tsumura & co, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tsumura & co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tsumura & co, Deals By Therapy Area, 2012 to YTD 2018 8
Tsumura & co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tsumura Forms Joint Venture with Ping An Insurance 10
Tsumura Plans to Form Joint Venture with Tianjin-based Drug Firm 11
Tsumura Raises USD243 Million in Public Offering of Shares 12
Tsumura to Raise USD134.3 Million in Public Offering of 0.23% Bonds Due 2024 13
Tsumura to Raise USD134.3 Million in Public Offering of 0.345% Bonds Due 2027 14
Tsumura & co, Key Competitors 15
Tsumura & co, Key Employees 16
Tsumura & co, Other Locations 17
Tsumura & co, Subsidiaries 17

List Of Figures


Tsumura & co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tsumura & co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tsumura & co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Tsumura and co (4540) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Tsumura & co (Tsumura) is a traditional pharmaceutical products company, which undertakes the manufacturing and sale of Kampo extract intermediates and granular Kampo formulations. Its product portfolio includes a range

USD 250 View Report

TSUMURA & CO Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

TSUMURA & CO Company Profile is a detailed strategic and analytical report on TSUMURA & CO. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

GS Engineering & Construction Corp (006360) - Financial and Strategic SWOT Analysis Review

GS Engineering & Construction Corp (006360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available